Data as of 1:33pm ET
| +0.52 / +4.28%|
The 2 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 26.25, with a high estimate of 27.50 and a low estimate of 25.00. The median estimate represents a +107.18% increase from the last price of 12.67.
The current consensus among 2 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.